Loading…
Loading…
was there anything included on CMS has identified duplicative members, how that could impact the risk pool
Regarding the exchanges, So firstly, I'm having a little bit of trouble bridging to your expected $5 billion of additional revenue
how much of a potential difference you think there could be now versus the next few months as you hit those checkpoints
what we just experienced with redeterminations, the large disenrollment from procedural reasons. And now with the new timeline starting '27
what percent of your MA Part D members are ready through their matching out-of-pocket limits. How does that compare to your expectations
for the investors who may still push back and say, okay, Elevance only achieved this healthy growth level through aggressive plan suppression tactics, and that the company still mispriced the business
Would it be fair to make this comparison and say the year-to-year set up into '27 actually feels even better than '25
if your reach fee-for-service cost trend for '25 is 8.5%, usually a pretty strong leading indicator for the rate notice
is there any level of membership growth percentage that you think if growth starts tracking to like 15%, 20%, 25%, where it could begin to potentially compromise earnings
In your prepared remarks, you mentioned remaining committed to individual MA margins of at least 3% over time. That change in wording from '27 to overtime
can you talk about your thoughts on the durability of long-term pricing? Should we think about '28 as sort of that starting year of more incremental changes lower?
On behavioral volumes, I just wanted to confirm, you're now expecting 2% to 3% growth in fourth quarter, but closer to the low end. And then should we expect next year to be consistently in that 2%...
how you're thinking about the potential ripple effect of Medicaid work requirements onto UHS
we should be thinking about behavioral health long-term margin targets as unchanged
I think they already submitted filed the CMS to raise the DPP payments to average commercial rates. Just any update there?
Are we talking an immediate large step-up in 2Q or is something more modest and then larger step-ups in 3Q, 4Q?
it be fair to say you're you might only be about a year or two away from getting back to the pre COVID levels. And then what is that path look like?
is the total current, I guess, payment upside $169 million across the two. And what do you typically recognize in terms of the flow through down into earnings
how do you expect the impact to Optum Health versus industry average?